Mitsubishi Tanabe Pharma Corporation approved the proposal to appoint a new Representative Director. Takashi Kobayashi will be Member of the Board from his current role of Representative Director, Senior Managing Executive Officer, in charge of Digital Transformation Department. The company also announced that Eizo Tabaru will be Representative Director, Managing Executive Officer, in charge of Corporate Management Department Corporate Communications Department, Legal & General Affairs Department, Japan Quality Assurance Office from his current role of Member of the Board, Managing Executive Officer, in charge of Corporate Strategy & Planning Department, NeuroDerm Office, Finance & Accounting Department, Corporate Communications Department. Planned date of change is April 1, 2020.